New clinical trial, HIV Vacc-4x in combination with Revlimid® (Lenalidomide)

Oslo – 25.08.11 – Bionor Pharma ASA Announces Exploratory Study of its Lead Therapeutic HIV-Vaccine Candidate Vacc-4x in Combination with Leading Cancer Drug The study will determine: 1. The ability of Vacc-4x to improve immune function in patients that fail to regain a healthy immune defense despite that their viral load is well controlled on conventional …

Read more

BIOtechNOW: International AIDS Conference Unveils Four New “Next Generation” Treatments for HIV

New data presented at the 2010 International AIDS Conference showed significant momentum for the emerging fields of therapeutic vaccines, anti-immune hyperactivation, and other immune based therapies for the treatment of HIV/AIDS. New data presented by researchers at the XVIII International AIDS Conference on Thursday, July 22 showed significant momentum for the emerging field of therapeutic vaccines, anti-immune …

Read more